Skip to main content

Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Lee, Beverly beverly.lee@nih.gov	5E532	Program Officer \| Community Oncology and Prevention Trials
	Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152	5E516	Nurse Consultant \| Community Oncology and Prevention Trials
	Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081	5E434	Program Specialist \| Community Oncology and Prevention Trials
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533	5E448	Program Officer \| Community Oncology and Prevention Trials
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Voss, Alyssa, M.P.H. alyssa.voss@nih.gov 240-204-3107		Writer/Editor \| Office of the Director Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials

Grants

PI Name	PI Organization	Title	Grant Number	Program Official
Washington, Karla	Washington University United States	Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care	5R01CA258311-05	Brennan Streck, Ph.D., RN, M.P.H.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-04	Eileen Dimond, R.N., M.S.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06	Rachel Altshuler, Ph.D.
Yu, Anthony Francis	Sloan-Kettering Inst Can Research United States	Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial	5R37CA273923-03	Eileen Dimond, R.N., M.S.
Bhatt, Vijaya Raj	University Of Nebraska Medical Center United States	Aging trajectories and outcomes of older adults with acute myeloid leukemia	5R37CA276928-03	Brennan Streck, Ph.D., RN, M.P.H.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-05	Rachel Altshuler, Ph.D.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-03	John Clifford, Ph.D.
Bryan, Angela	University Of Colorado United States	Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC	5R01CA284860-03	Brennan Streck, Ph.D., RN, M.P.H.
Acharya, Munjal M	University Of California-Irvine United States	Stem cell-derived exosomes to ameliorate chemobrain	5R01CA262213-03	Rachel Altshuler, Ph.D.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-04	Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-04	Rachel Altshuler, Ph.D.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy	3R01CA245054-05S1	Rachel Altshuler, Ph.D.
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	4R01CA249939-02	Rachel Altshuler, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03	Rachel Altshuler, Ph.D.